510(k) Report

510(k) · Cleared

Cleared

TLX SRAs and TLX Gold Abutments

K213063510(k) TraditionalCleared Apr 8, 2022197-day reviewClass II21 CFR 872.3630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Institut Straumann AG · NHA Abutment, Implant, Dental, Endosseous

Cleared on Apr 8, 2022 as substantially equivalent to K203355 (Institut Straumann AG, 2021) after a 197-day review. Its family tree reaches back 3 generations to 2019. 1 later device descends from it.

Decided
Apr 8, 2022
Review
197 days
Class
Class II
Product code
NHA
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K190040 (2019). 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backK190040 Straumann BLX Line Extension - New AbutmentsInstitut Straumann AG · 2019
  2. 2 generations backK193046 Straumann® Retentive System – Novaloc TiN AbutmentsInstitut Straumann AG · 2020
  3. 1 generation backK203355 Straumann TLX Novaloc and Cementable AbutmentsInstitut Straumann AG · 2021
  4. This deviceK213063 TLX SRAs and TLX Gold AbutmentsInstitut Straumann AG · 2022
  5. Descendant · cites it directly · 0 of its ownK231566 ICX-Implant SystemMedentis Medical GmbH · 2024

Most influential descendants

Showing 1 of 1 · See all
  • K231566ICX-Implant SystemMedentis Medical GmbH · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K190040Straumann BLX Line Extension - New AbutmentsInstitut Straumann AG2019—
−2K193046Straumann® Retentive System – Novaloc TiN AbutmentsInstitut Straumann AG2020—
−1K203355Straumann TLX Novaloc and Cementable AbutmentsInstitut Straumann AG2021—
0 (this device)K213063TLX SRAs and TLX Gold AbutmentsInstitut Straumann AG2022—
+1K231566ICX-Implant SystemMedentis Medical GmbH2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
FIG. 1 — Lineage of K213063, 2019–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NHA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NHA device

  1. #1 K222288 DESS Dental Smart Solutionsscore 30.6 · 19 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K203355Straumann TLX Novaloc and Cementable Abutments
Summary page 5
…l 510(k) TLX SRAs and TLX Gold Abutments 510(k) Summary Predicate Device(s) Primary Predicate: • K203355 - Straumann TLX Novaloc and Cementable Abutments - Cementable Abutments Reference Devices: • K181703 - Straumann®…
Institut Straumann AG2021—
†K181703Straumann BLX Line Extension - Implants, SRAs and Anatomic AbutmentsInstitut Straumann AG2018—
†K200597Straumann BLX Gold AbutmentsStraumann USA, LLC (On Behalf of Institut Straumann Ag)2020—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K231566ICX-Implant SystemMedentis Medical GmbH20240

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 3 years and passes through 1 company; a new generation was cleared every 1.1 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K231566 (Medentis Medical GmbH, 2024) has gone furthest, with 0 descendants of its own.

How does its category compare?

All NHA devices

NHA Abutment, Implant, Dental, Endosseous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · NHA

40in 2025

2007: 382008: 312009: 302010: 192011: 312012: 252013: 222014: 272015: 292016: 382017: 312018: 312019: 282020: 382021: 292022: 332023: 512024: 432025: 402026 (partial year): 23
2007high 51 (2023) · low 19 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NHA

147in 2025

2007: 91 days median2008: 90 days median2009: 95 days median2010: 162 days median2011: 130 days median2012: 171 days median2013: 184 days median2014: 160 days median2015: 151 days median2016: 202 days median2017: 188 days median2018: 200 days median2019: 160 days median2020: 153 days median2021: 211 days median2022: 142 days median2023: 147 days median2024: 158 days median2025: 147 days median2026 (partial year): 169 days median
2007high 211 (2021) · low 90 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NHA

1in 2025

2007: 12008: 22011: 52012: 12013: 12015: 12016: 362017: 22018: 12020: 72023: 32025: 12026 (partial year): 3
2007high 36 (2016) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NHA

838in 2025

2007: 12008: 82009: 302010: 612011: 562012: 52013: 1432014: 1462015: 8582016: 3142017: 5772018: 5912019: 5302020: 4582021: 5462022: 4972023: 6182024: 6352025: 838
2007high 858 (2015) · low 1 (2007)2025

MAUDE reports naming product code NHA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007389111
2008319028
20093095030
201019162061
201131130556
20122517115
2013221841143
2014271600146
2015291511858
20163820236314
2017311882577
2018312001591
2019281600530
2020381537458
2021292110546
2022331420497
2023511473618
2024431580635
2025401471838
2026231693—

What is it indicated for?

TLX SRAs

Straumann® abutments are indicated to be placed into Straumann® dental implants to provide a support structure for the functional and esthetic oral rehabilitation of edentulous or partially edentulous patients with crowns, bridges or full-arch prostheses.

TLX Gold Abutments

Straumann® abutments are indicated to be placed into Straumann® dental implants to provide a support structure for the functional and esthetic oral rehabilitation of edentulous or partially edentulous patients with crowns, bridges or full-arch prostheses.

Copings are indirectly connected to the endosseous dental implant and are indicated for use as an aid in prosthetic rehabilitations.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K213063: TLX SRAs and TLX Gold Abutments.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213063

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026